Ranibizumab ophthalmic Disease Interactions
There are 2 disease interactions with ranibizumab ophthalmic:
Intravitreal Injections (Includes Ranibizumab ophthalmic) ↔ Ocular Infections
Severe Potential Hazard, High plausibility
Applies to: Ocular Infection, Uveitis, Orbital Infection, Infectious Endophthalmitis, Infectious Optic Neuritis
Intravitreal administration of medications is contraindicated in patients with active intraocular inflammation or ocular/periocular infections, since endophthalmitis can occur following intravitreal injections. Patients should be advised to seek immediate medical attention from an ophthalmologist if the eye becomes red, photosensitive or painful, or if there is a change in vision in the days following an injection.
Ranibizumab Intravitreal Injection (Includes Ranibizumab ophthalmic) ↔ Increased Intraocular Pressure
Moderate Potential Hazard, Moderate plausibility
Applies to: Glaucoma/Intraocular Hypertension
Increases in intraocular pressure have been reported both pre- injection and post- injection (at 60 minutes) while being treated with ranibizumab. Intraocular pressure should be monitored prior and following intravitreal injection with ranibizumab and managed appropriately.
ranibizumab ophthalmic drug Interactions
There is 1 drug interaction with ranibizumab ophthalmic
Drug Interaction Classification
Do not stop taking any medications without consulting your healthcare provider.